Related content

Predicting the FSH threshold dose in women with WHO Group II anovulatory infertility failing to ovulate or conceive on clomiphene citrate

By Nyboe Andersen Anders   Balen Adam   Platteau Peter   Devroey Paul   Helmgaard Lisbeth   Arce Joan-Carles  

Human Reproduction, Vol. 23, Iss. 6, 2008-06 ,pp. : 1424-1430

Oxford University Press

Access to resources Recommend Favorite

Recurrent partial hydatidiform mole, with a first twin pregnancy, after treatment with clomiphene citrate

By Tica Andrei Adrian   Tica Oana Sorina   Georgescu Claudia Valentina   Mixich Francisc   Tica Vlad Justin   Berceanu Sabina   Ebanca Elena   Patrascu Anca   Simionescu Cristina  

Gynecological Endocrinology, Vol. 25, Iss. 8, 2009-08 ,pp. : 514-519

Informa Healthcare

Access to resources Recommend Favorite

Clomiphene citrate utilization in the Netherlands 1998–2007

By Wang H.   Land J.A.   Bos H.J.   Bakker M.K.   de Jong-van den Berg L.T.W.  

Human Reproduction, Vol. 26, Iss. 5, 2011-05 ,pp. : 1227-1231

Oxford University Press

Access to resources Recommend Favorite

Clomiphene citrate in the twenty-first century

By Nasseri Souzan   Ledger William  

Human Fertility, Vol. 4, Iss. 3, 2001-08 ,pp. : 145-151

Informa Healthcare

Access to resources Recommend Favorite

The association between follicular size on human chorionic gonadotropin day and pregnancy rate in clomiphene citrate treated polycystic ovary syndrome patients

By Farhi Jacob   Orvieto Raoul   Gavish Oz   Homburg Roy  

Gynecological Endocrinology, Vol. 26, Iss. 7, 2010-07 ,pp. : 546-548

Informa Healthcare

Access to resources Recommend Favorite